APA (7th ed.) Citation

Fabisiak, A., Fabisiak, N., Mokrowiecka, A., Malecka‐Panas, E., Jacenik, D., Kordek, R., . . . Fichna, J. (2021). Novel selective agonist of GPR18, PSB‐KK‐1415 exerts potent anti‐inflammatory and anti‐nociceptive activities in animal models of intestinal inflammation and inflammatory pain. Neurogastroenterology & Motility, 33(3), 1. https://doi.org/10.1111/nmo.14003

Chicago Style (17th ed.) Citation

Fabisiak, Adam, Natalia Fabisiak, Anna Mokrowiecka, Ewa Malecka‐Panas, Damian Jacenik, Radzislaw Kordek, Marta Zielińska, Katarzyna Kieć‐Kononowicz, and Jakub Fichna. "Novel Selective Agonist of GPR18, PSB‐KK‐1415 Exerts Potent Anti‐inflammatory and Anti‐nociceptive Activities in Animal Models of Intestinal Inflammation and Inflammatory Pain." Neurogastroenterology & Motility 33, no. 3 (2021): 1. https://doi.org/10.1111/nmo.14003.

MLA (9th ed.) Citation

Fabisiak, Adam, et al. "Novel Selective Agonist of GPR18, PSB‐KK‐1415 Exerts Potent Anti‐inflammatory and Anti‐nociceptive Activities in Animal Models of Intestinal Inflammation and Inflammatory Pain." Neurogastroenterology & Motility, vol. 33, no. 3, 2021, p. 1, https://doi.org/10.1111/nmo.14003.